Characterization of Adult Subjects for Asthmatic Research Studies (CASA)
Verified January 2014 by University of California, San Francisco
Information provided by (Responsible Party):
John V. Fahy, University of California, San Francisco
First received: January 6, 2012
Last updated: January 21, 2014
Last verified: January 2014
This study is designed to characterize subjects in terms of the nature and severity of their asthma and in terms of conditions that may alter the clinical expression of asthma. Some features will be obtained in all subjects. These include a medical history and baseline lung function tests. This characterization forms the basis for our database that facilitates research protocols.
||Time Perspective: Cross-Sectional
||Characterization of Adult Subjects for Asthmatic Research Studies
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||July 2017 (Final data collection date for primary outcome measure)
Otherwise healthy asthmatic subjects
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Asthmatics and healthy control
- History of lung disease other than asthma
- An upper respiratory tract infection or an exacerbation of their asthma within the preceding 4-6 weeks.
- Persons who have smoked > 5 cigarettes per month and have a total pack-year smoking history > 10 packs.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01508078
|University of California, San Francisco
|San Francisco, California, United States, 94143 |
|Contact: John Fahy, MD 415-502-4849 |
University of California, San Francisco
||John Fahy, MD
||University of California, San Francisco
No publications provided
||John V. Fahy, Professor in Residence, University of California, San Francisco
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 6, 2012
||January 21, 2014
||United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 10, 2014
Respiratory Tract Diseases
Lung Diseases, Obstructive
Immune System Diseases